Insider · CIK 0001276551

BRANCACCIO JOHN P

Reports to the SEC for 7 companies · LONDON

sec.gov

Transactions

Companies

Filings

CIK

0001276551

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-07-21	OKYOOKYO Pharma LtdP Purchase	Director	PPurchase	+5,000 sh	$1.48	+$7,385	35,201
2026-07-21	OKYOOKYO Pharma LtdA Award	Director	AAward	+5,000 sh	$1.48	+$7,385	35,201
2026-06-08	OKYOOKYO Pharma Ltd · OptionA Award	Director	AAward	+6,500 sh	$1.85	+$12K	138,394
2024-02-19	HEPAHepion Pharmaceuticals, Inc. · Stock OptionsA Award	Director, Chairman	AAward	+85K sh	—	—	99,563
2023-09-15	OKYOOKYO Pharma LtdP Purchase	Director	PPurchase	+16.7K sh	$1.50	+$25K	16,670
2022-06-09	CRDFCardiff Oncology, Inc. · Stock OptionsJ Other	Former Director	JOther	+28.9K sh	—	—	125,317
2022-06-09	CRDFCardiff Oncology, Inc. · Stock OptionsJ Other	Former Director	JOther	+22K sh	—	—	125,317
2022-06-09	CRDFCardiff Oncology, Inc. · Stock OptionsJ Other	Former Director	JOther	+223 sh	—	—	125,317
2022-06-09	CRDFCardiff Oncology, Inc. · Stock OptionsJ Other	Former Director	JOther	+223 sh	—	—	125,317
2022-06-09	CRDFCardiff Oncology, Inc. · Stock OptionsJ Other	Former Director	JOther	+530 sh	—	—	125,317
2022-06-09	CRDFCardiff Oncology, Inc. · Stock OptionsJ Other	Former Director	JOther	+26.8K sh	—	—	125,317
2022-06-09	CRDFCardiff Oncology, Inc. · Stock OptionsJ Other	Former Director	JOther	+195 sh	—	—	125,317
2022-06-09	CRDFCardiff Oncology, Inc. · Stock OptionsJ Other	Former Director	JOther	+755 sh	—	—	125,317
2022-06-09	CRDFCardiff Oncology, Inc. · Stock OptionsJ Other	Former Director	JOther	+44.7K sh	—	—	125,317
2022-03-09	CRDFCardiff Oncology, Inc. · Stock OptionsA Award	Former Director	AAward	+26.8K sh	—	—	125,317
2021-06-10	CRDFCardiff Oncology, Inc. · Stock OptionsA Award	Former Director	AAward	+22K sh	—	—	98,517
2021-05-18	HEPAHepion Pharmaceuticals, Inc. · Stock OptionsA Award	Director, Chairman	AAward	+200K sh	—	—	291,332
2021-03-22	CRDFCardiff Oncology, Inc.P Purchase	Former Director	PPurchase	+3,000 sh	$10.95	+$32.9K	12,260
2020-12-02	HEPAHepion Pharmaceuticals, Inc.P Purchase	Director, Chairman	PPurchase	+7,000 sh	$1.53	+$10.7K	7,008
2020-08-19	HEPAHepion Pharmaceuticals, Inc. · Stock OptionsA Award	Director, Chairman	AAward	+30K sh	—	—	91,332
2020-06-17	CRDFCardiff Oncology, Inc. · Stock OptionsA Award	Former Director	AAward	+28.9K sh	—	—	76,517
2020-05-14	CRDFCardiff Oncology, Inc.P Purchase	Former Director	PPurchase	+6,993 sh	$1.43	+$9,999.99	9,260
2020-04-03	HEPAHepion Pharmaceuticals, Inc. · Stock OptionsA Award	Director, Chairman	AAward	+60K sh	—	—	61,275
2019-07-24	HEPAHepion Pharmaceuticals, Inc. · Stock OptionsA Award	Director, Chairman	AAward	+970 sh	—	—	1,275
2019-06-20	CRDFCardiff Oncology, Inc. · Stock OptionsA Award	Former Director	AAward	+44.7K sh	—	—	47,806
2018-07-04	SYNERGY PHARMACEUTICALS LLCStock OptionsM Exercise/Conversion	Director	MExercise/Conversion	−50K sh	—	—	506,173
2018-07-04	SYNERGY PHARMACEUTICALS LLCF Tax Payment	Director	FTax Payment	−13.9K sh	—	—	116,571
2018-07-04	SYNERGY PHARMACEUTICALS LLCM Exercise/Conversion	Director	MExercise/Conversion	+50K sh	$0.50	+$25K	130,467
2018-07-03	HEPAHepion Pharmaceuticals, Inc. · WarrantsP Purchase	Director, Chairman	PPurchase	+1,725 sh	$1000.00	+$1.73M	1,725
2018-07-03	HEPAHepion Pharmaceuticals, Inc. · Series C Convertible Preferred StockP Purchase	Director, Chairman	PPurchase	+3 sh	$1000.00	+$3,000	3
2018-06-16	SYNERGY PHARMACEUTICALS LLCStock OptionsA Award	Director	AAward	+115K sh	—	—	556,196
2018-06-08	CRDFCardiff Oncology, Inc.P Purchase	Former Director	PPurchase	+10K sh	$0.80	+$8,000	13,598
2018-06-08	CRDFCardiff Oncology, Inc.P Purchase	Former Director	PPurchase	+10K sh	$0.80	+$8,000	53,167
2018-04-02	SYNERGY PHARMACEUTICALS LLCStock OptionsM Exercise/Conversion	Director	MExercise/Conversion	−50K sh	—	—	441,446
2018-04-02	SYNERGY PHARMACEUTICALS LLCM Exercise/Conversion	Director	MExercise/Conversion	+50K sh	$0.50	+$25K	76,944
2018-01-23	CRDFCardiff Oncology, Inc. · Stock OptionsA Award	Former Director	AAward	+54.3K sh	—	—	246,130
2018-01-02	CRDFCardiff Oncology, Inc.M Exercise/Conversion	Former Director	MExercise/Conversion	+16.7K sh	—	—	43,167
2018-01-02	CRDFCardiff Oncology, Inc. · Restricted Stock UnitsM Exercise/Conversion	Former Director	MExercise/Conversion	−16.7K sh	—	—	0
2017-10-04	CRDFCardiff Oncology, Inc. · Stock OptionsA Award	Former Director	AAward	+38.1K sh	—	—	191,808
2017-09-02	CRDFCardiff Oncology, Inc. · Restricted Stock UnitsM Exercise/Conversion	Former Director	MExercise/Conversion	−12.7K sh	—	—	16,667
2017-09-02	CRDFCardiff Oncology, Inc.M Exercise/Conversion	Former Director	MExercise/Conversion	+12.7K sh	—	—	26,500
2017-06-28	SYNERGY PHARMACEUTICALS LLCStock OptionsA Award	Director	AAward	+14K sh	—	—	481,372
2017-06-28	SYNERGY PHARMACEUTICALS LLCStock OptionsD Disposition to Issuer	Director	DDisposition to Issuer	−14K sh	—	—	467,372
2017-06-28	SYNERGY PHARMACEUTICALS LLCStock OptionsA Award	Director	AAward	+62.5K sh	—	—	481,372
2017-05-26	SYNERGY PHARMACEUTICALS LLCP Purchase	Director	PPurchase	+6,500 sh	$3.59	+$23.3K	30,444
2017-01-02	CRDFCardiff Oncology, Inc. · Restricted Stock UnitsA Award	Former Director	AAward	+12.7K sh	—	—	29,334
2017-01-02	CRDFCardiff Oncology, Inc. · Restricted Stock UnitsA Award	Former Director	AAward	+16.7K sh	—	—	16,667
2017-01-02	CRDFCardiff Oncology, Inc. · Restricted Stock UnitsA Award	Former Director	AAward	+16.7K sh	—	—	16,667
2016-09-19	SYNERGY PHARMACEUTICALS LLCStock OptionsM Exercise/Conversion	Director	MExercise/Conversion	−1,079 sh	—	—	418,872
2016-09-19	SYNERGY PHARMACEUTICALS LLCStock OptionsM Exercise/Conversion	Director	MExercise/Conversion	−1,439 sh	—	—	419,951

Recent filings

Accepted (ET)
Aug 74/A
BRANCACCIO JOHN P0001493152-26-036585
SEC(opens sec.gov)
Jul 234
BRANCACCIO JOHN P0001493152-26-034405
SEC(opens sec.gov)
Jun 104
BRANCACCIO JOHN P0001493152-26-028133
SEC(opens sec.gov)
Feb 214
BRANCACCIO JOHN P0001493152-24-007463
SEC(opens sec.gov)
Sep 284
BRANCACCIO JOHN P0001493152-23-034486
SEC(opens sec.gov)
Jun 94
BRANCACCIO JOHN P0001628280-22-016731
SEC(opens sec.gov)
Mar 104
BRANCACCIO JOHN P0001628280-22-005789
SEC(opens sec.gov)
Jun 144
BRANCACCIO JOHN P0001628280-21-012171
SEC(opens sec.gov)
May 204
BRANCACCIO JOHN P0001104659-21-069936
SEC(opens sec.gov)
Mar 224
BRANCACCIO JOHN P0001628280-21-005297
SEC(opens sec.gov)
Dec 24
BRANCACCIO JOHN P0001104659-20-131656
SEC(opens sec.gov)
Aug 214
BRANCACCIO JOHN P0001104659-20-097596
SEC(opens sec.gov)

Companies

Address

14-15 CONDUIT ST

LONDON, W1S 2XJ